{"id":"W2760163521","doi":"10.1182/bloodadvances.2017007112","title":"Safety, pharmacokinetics, and reversal of apixaban anticoagulation with andexanet alfa","year":2017,"lang":"en","type":"article","venue":"Blood Advances","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University","funders":"LEO Pharma; Servier; Daiichi-Sankyo; Pfizer; McMaster University; CSL Behring; Celgene; Bristol-Myers Squibb","keywords":"Apixaban; Pharmacokinetics; Medicine; Pharmacology; Rivaroxaban; Internal medicine; Warfarin; Atrial fibrillation","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001107323,0.0002300097,0.0004290152,0.0001146586,0.0001375633,0.0004846869,0.0001721348,0.00024254,0.001819805],"category_scores_gemma":[0.00240435,0.00009524574,0.0002635577,0.0001795025,0.0002421691,0.0002940642,0.0001265091,0.0006662164,0.0003815262],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001647929,"about_ca_system_score_gemma":0.0003672932,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003058827,"about_ca_topic_score_gemma":0.0003132229,"domain_scores_codex":[0.9992995,0.0003668178,0.00005824671,0.00005944313,0.0001635924,0.0000523727],"domain_scores_gemma":[0.999273,0.0001844418,0.0002823565,0.0001048198,0.00007987209,0.00007554684],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.1529739,0.006807758,0.03257934,0.0009318932,0.0006387561,0.0007673532,0.0008245675,0.001439778,0.1553513,0.001096636,0.005439362,0.6411492],"study_design_scores_gemma":[0.04286619,0.2539743,0.5301588,0.00027542,0.001724915,0.01264352,0.0006569078,0.00759553,0.100798,0.001880918,0.04728035,0.0001451696],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.990171,0.002177408,0.001715683,0.0002623325,0.00004643737,0.0002492171,0.0003136958,0.00005374267,0.005010508],"genre_scores_gemma":[0.9972222,0.0004929082,0.0006146572,0.00007052532,0.00003764444,0.0001006886,0.0001713253,0.00001020879,0.001279864],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001819805,"threshold_uncertainty_score":0.006087899,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03421385427240273,"score_gpt":0.3384299350468502,"score_spread":0.3042160807744475,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}